Description |
glycogen phosphorylase, muscle associated |
S100 calcium binding protein A1 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
- Pyridoxal phosphate
- Beta-D-Glucopyranose Spirohydantoin
- (5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione
- alpha-D-glucose 6-phosphate
- N-beta-D-glucopyranosylacetamide
- Monofluorophosphate ion
- Beta-D-Glucose
- 3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Nojirimycine Tetrazole
- Indirubin-5-sulphonate
- 2-Deoxy-Glucose-6-Phosphate
- C-(1-hydrogyl-beta-D-glucopyranosyl) formamide
- alpha-D-glucopyranosyl-2-carboxylic acid amide
- alpha-D-glucose-1-phosphate
- 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one
- 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
- N-acetyl-N'-beta-D-glucopyranosyl urea
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
- C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
- 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
- CP-320626
- (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
- 8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
- Alvocidib
- 1-deoxy-1-methoxycarbamido-beta-D-glucopyranose
- N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide
- 1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide
- 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
- 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
- N(6)-(pyridoxal phosphate)-L-lysine
- Heptulose-2-Phosphate
- N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine
- Dexfosfoserine
- 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide
- Inosinic Acid
- 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
- 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
- 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
- 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
- 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
- (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
- ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid
- (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
- 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
- (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
|
|
Diseases |
|
|
GWAS |
|
|
Interacting Genes |
31 interacting genes:
AGTPBP1
ARID1B
CDC42BPB
CLASP2
DNM2
ERO1B
FADS2
FAM110A
IGBP1
INTS4
LMNA
NIPSNAP2
NTAQ1
PDE4DIP
POMP
PPP1CA
PPP1R3B
PPP2CA
PRKAB2
PYGB
PYGL
S100A1
SGCG
SRP72
TOP1
TRAPPC2
TRIM54
TRIM55
TRIM63
TTN
WWP1
|
31 interacting genes:
ACTA1
AGER
ANXA6
ATP2A2
BEX3
BIK
CACYBP
CAPZA1
CEP20
DES
FKBP4
GFAP
GJA1
MDM2
NIF3L1
PGM1
PLB1
PLEKHF2
PLN
PPID
PYGM
REL
RYR1
S100A2
S100A3
S100A4
S100B
S100P
S100Z
SYN1
TP53
|
Entrez ID |
5837 |
6271 |
HPRD ID |
01986 |
01489 |
Ensembl ID |
ENSG00000068976
|
ENSG00000160678
|
Uniprot IDs |
P11217
|
A0A0S2Z4H2
P23297
|
PDB IDs |
1Z8D
|
2L0P
2LHL
2LLS
2LLT
2LLU
2LP2
2LP3
2LUX
2M3W
5K89
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|